A new study shows how minority patients are effectively disqualified from receiving the latest cystic fibrosis drugs approved only for people with mutations more common among white patients.
As its supply of COVID-19 vaccines increases, UC San Francisco is expanding its vaccination efforts to those most at risk – the elderly and health care workers in the community